UNC1999
-
- Applikation
- Inhibition (Inh)
- Verwendungszweck
- Methyltransferase inhibitor
- Produktmerkmale
- UNC1999 is an orally active, highly selective inhibitor of both wild-type and mutant EZH1 and EZH2 lysine methyltransferases (IC50's = 45 nM and 2 nM respectively). Inhibition of EZH2 with UNC1999 enhanced the efficacy of gefitinib in suppressing the proliferation of colon cancer cells. It suppresses global H3K27 trimethylation/demethylation and inhibits the growth of mixed lineage leukemia (MLL)-rearranged leukemia cells.
- Reinheit
- >98 %
- Chemical Name
- N-[(6-methyl-2-oxo-4-propyl-1H-pyridin-3-yl)methyl]-1-propan-2-yl-6-[6-(4-propan-2-ylpiperazin-1-yl)pyridin-3-yl]indazole-4-carboxamide
- Formel
- C33H43N7O2
- Löslichkeit
- Soluble in DMSO (up to 10 mg/ml).
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Powder
- Lagerung
- -20 °C
-
- Hintergrund
- Epigenetics,Proliferation,Protein methyltransferase,Cancer,Posttranslational modification,Chromatin
- Molekulargewicht
- 569.74
- CAS-Nummer
- 1431612-23-5
-